http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-WO2002012261-A1
Outgoing Links
| Predicate | Object |
|---|---|
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07H19-01 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07H17-08 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P33-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P33-10 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P33-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P33-10 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-7048 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07H17-08 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07H19-01 |
| filingDate | 2001-08-08-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationDate | 2004-01-15-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | JP-WO2002012261-A1 |
| titleOfInvention | Evermectin derivative |
| abstract | General formula (I) having antiparasitic activity: <-X ---- Y- represents -CH = CH-, etc., between R 2 and 5-position carbon atoms ---- represents a single bond or a double bond, R 1 is a lower alkyl group , A formyl group, a carboxyl group, a lower alkoxycarbonyl group (the lower alkyl part of the lower alkoxycarbonyl group may be substituted with a heterocyclic group), and R 1a represents a hydrogen atom, but R 1 is lower. when an alkoxycarbonyl group is, R 1a may further represent a lower alkoxycarbonyl group, R 2 when ---- between R 2 and 5-position carbon atom is a single bond hydroxyl represents a group, R 2 and 5-position ---- together with the carbon atoms of R 2 is 5-position when is a double bond hydroximic group {-C between carbon atoms (= NOH) }, etc. to form a, R 3 is a hydroxyl group or a tri-lower a Provides a compound or a salt thereof represented Kill silyl group>. |
| priorityDate | 2000-08-09-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 110.